Endothelin antagonists and hypertension: a question of dose?

Hypertension. 2002 Sep;40(3):e1-2; author reply e1-2. doi: 10.1161/01.hyp.0000028980.24709.68.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Endothelin Receptor Antagonists*
  • Forearm / blood supply
  • Humans
  • Hypertension / physiopathology*
  • Indans / administration & dosage*
  • Indans / pharmacology
  • Infusions, Intra-Arterial
  • Peptides, Cyclic / administration & dosage*
  • Peptides, Cyclic / pharmacology
  • Regional Blood Flow / drug effects
  • Vasodilation / drug effects

Substances

  • Endothelin Receptor Antagonists
  • Indans
  • Peptides, Cyclic
  • 1H-Indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1S,2R,3S)-
  • cyclo(Trp-Asp-Pro-Val-Leu)